Submodule
Clinical Spectrum and Vascular Biology
PAD is systemic atherosclerosis expressed through silent hemodynamic disease, exertional ischemia, chronic tissue threat, or sudden limb-threatening perfusion loss.
- Asymptomatic PAD
- Claudication
- CLTI
- ALI
- Risk amplifiers
Risk persists without classic pain
Walking reveals flow limitation
Rest pain, wound, or gangrene
Sudden perfusion loss threatens viability
Treat PAD as systemic atherosclerosis
Lower-extremity plaque and thrombosis affect walking and tissue perfusion, but the same patient also faces myocardial infarction, stroke, and death. Major adverse cardiovascular events and major adverse limb events are parallel outcomes, so every plan needs both systemic prevention and limb care.
Recognize silent and atypical disease
Many people with objective PAD report no classic calf pain. They may walk too little to provoke symptoms, describe fatigue or weakness, or attribute limitation to age, arthritis, neuropathy, or lung disease. A normal symptom history does not erase abnormal physiology or functional impairment.
Separate claudication from limb threat
Claudication is reproducible exertional muscle discomfort relieved by rest. CLTI is chronic ischemic rest pain, nonhealing wound, or gangrene with objective arterial disease. ALI is a sudden perfusion decline, generally under two weeks, with pain, pallor, pulse loss, coolness, sensory loss, or weakness. These states have different time horizons and goals.
Include risk amplifiers and inequity
Diabetes, tobacco, kidney disease, polyvascular disease, age, depression, mobility loss, geography, structural racism, and access barriers influence detection, treatment, amputation, and survival. They are clinical data that should change screening, intensity, follow-up, and team design.
Quick check
Submodule
Physiologic Diagnosis and Anatomic Evaluation
Testing begins with a clinical question and progresses from resting physiology to exercise or tissue-perfusion studies, then to anatomy when intervention or uncertainty makes imaging useful.
- Resting ABI
- Exercise ABI
- Noncompressible vessels
- Toe and tissue perfusion
- Vascular imaging
Classify compressible vessels
Evaluate normal resting ABI with symptoms
Support CLTI assessment
Do not replace physiology by default
Measure the ABI correctly
Use Doppler systolic pressures in both arms and at the dorsalis pedis and posterior tibial arteries. Calculate each leg using the higher ankle pressure divided by the higher brachial pressure. Interpret the result with waveforms, technique, symptoms, diabetes, kidney disease, and edema.
Use exercise when rest is not enough
A fixed stenosis may preserve pressure at rest yet fail when muscle demand rises. When symptoms suggest PAD but the resting ABI is normal or borderline, standardized exercise with prompt postexercise ankle pressures can reproduce symptoms and expose a hemodynamic decline.
Work around calcified vessels
Diabetes and kidney disease can produce stiff, poorly compressible ankle arteries and a falsely high ABI. Toe-brachial index and digital waveforms often provide better physiology. In CLTI, toe pressure, transcutaneous oxygen, or skin-perfusion pressure can add information about local healing potential.
Image only when anatomy changes care
Duplex ultrasound, CT angiography, MR angiography, and catheter angiography answer different anatomic questions. Select the modality according to kidney function, contrast risk, calcification, devices, prior intervention, and whether revascularization is being planned.
Quick check
Submodule
Cardiovascular and Limb-Risk Pharmacotherapy
The medication plan protects several vascular beds at once and must distinguish single antiplatelet therapy, vascular-dose dual-pathway therapy, and full anticoagulation.
- Aspirin or clopidogrel
- Rivaroxaban 2.5 mg twice daily plus aspirin
- High-intensity statin
- Blood pressure and diabetes
- Tobacco treatment
Symptomatic PAD foundation
Balance ischemia with bleeding
Aim for at least 50 percent LDL reduction
Treat the whole vascular patient
Choose antithrombotic intensity deliberately
Symptomatic PAD warrants single antiplatelet therapy with aspirin or clopidogrel. In selected symptomatic patients and after lower-extremity revascularization, rivaroxaban 2.5 mg twice daily plus low-dose aspirin reduces cardiovascular and limb events when bleeding risk is acceptable.
Do not confuse vascular dose with full anticoagulation
The PAD regimen uses a specific low rivaroxaban dose with aspirin. Full-intensity oral anticoagulation should not be used for PAD alone. If atrial fibrillation, venous thromboembolism, or another indication exists, define that indication and rationalize any accompanying antiplatelet therapy.
Treat PAD as clinical ASCVD
Use high-intensity statin therapy with a goal of at least 50 percent LDL reduction. If LDL remains at least 70 mg/dL on maximally tolerated statin, current guidance supports adding ezetimibe or a PCSK9 inhibitor. Pressure below 130 over 80 is the general target when tolerated.
Treat diabetes and tobacco exposure as vascular therapy
For type 2 diabetes, GLP-1 receptor agonists and SGLT2 inhibitors with cardiovascular benefit can reduce major events when appropriate. Tobacco treatment should combine repeated assessment, behavioral support, and pharmacotherapy rather than a one-time warning.
Quick check
Submodule
Exercise, Claudication Therapy, and Foot Protection
Structured exercise is a core treatment, cilostazol serves a selected symptom role, and preventive foot care protects tissue with limited reserve.
- Supervised exercise
- Structured community exercise
- Cilostazol
- Ineffective therapies
- Preventive foot care
Supervised or structured community program
Avoid in heart failure
Prevent small injuries from becoming limb threats
Symptoms alone can underestimate impairment
Prescribe exercise as treatment
Supervised exercise therapy and structured community programs with behavioral support improve walking performance, function, and quality of life. The prescription includes frequency, intensity, time, and type, with progression and reassessment. Unstructured advice to walk more is not an equivalent intervention.
Adapt the program without abandoning structure
Patients with balance problems, joint disease, amputation, or severe walking limitation may benefit from arm ergometry, recumbent stepping, or another structured nonwalking program. Foot status, cardiac safety, transport, schedule, footwear, and social support influence completion.
Use cilostazol only in an eligible phenotype
Cilostazol can improve claudication symptoms and walking distance. It should not be used in heart failure of any severity. Review pulse, palpitations, headache, bleeding therapy, CYP3A and CYP2C19 interactions, and whether a defined trial produces meaningful functional benefit.
Protect the foot before it becomes threatened
Inspect skin, callus, nails, deformity, sensation, footwear, temperature, and pulses. Teach daily self-inspection and early reporting. Neuropathy can remove pain as a warning, while poor perfusion reduces the capacity to heal a small injury.
Quick check
Submodule
Revascularization and Longitudinal Care
A procedure is chosen for a specific functional or limb-preservation goal and remains one part of lifelong medical, exercise, foot, and surveillance care.
- Claudication indication
- CLTI indication
- Endovascular and surgical choice
- Postprocedure therapy
- Longitudinal follow-up
Match lesion to symptoms
Consider durability and patient risk
Procedure does not cure atherosclerosis
Watch patency, wound, and function
Use a patient-centered indication
For functionally limiting claudication, revascularization is reasonable after an inadequate response to guideline therapy and structured exercise. If function and quality of life are acceptable, a procedure offers no established preventive benefit. For CLTI, the goal shifts to tissue healing, pain relief, and preservation of a functional limb.
Match approach to anatomy and patient reserve
Endovascular, surgical, and hybrid approaches differ in invasiveness, durability, conduit needs, wound burden, and repeat-intervention risk. Anatomy, life expectancy, frailty, kidney and cardiac risk, available vein, infection, patient preference, and local expertise belong in the choice.
Continue disease treatment after flow is restored
Revascularization does not cure atherosclerosis. Continue lipid, pressure, diabetes, tobacco, antithrombotic, exercise, and foot care. Document postprocedure antithrombotic purpose and duration so temporary combinations do not become accidental indefinite therapy.
Follow symptoms, function, and tissue
All patients need longitudinal examination and risk-factor follow-up. New symptoms after revascularization warrant ABI and arterial duplex assessment. A patent artery is not the only outcome: walking, wound healing, pain, mobility, recurrent events, and access to care matter.
Quick check
Submodule
Limb-Threatening and Acute Ischemia
CLTI and ALI demand rapid physiology, team coordination, perfusion restoration, tissue care, and longitudinal rehabilitation measured against limb function and survival.
- WIfI staging
- ALI viability
- Urgent reperfusion
- Wound and infection care
- Functional limb preservation
Stage wound, ischemia, and infection
Determine viability immediately
Target the threatened tissue
Preserve a functional limb
Stage chronic limb threat
The WIfI framework organizes wound, ischemia, and foot infection. It helps estimate amputation risk and expected benefit from revascularization, but it does not replace anatomy, function, nutrition, comorbidity, goals, or local tissue expertise.
Assess acute viability at the bedside
In ALI, pain and pulse loss establish concern, while sensory deficit, motor weakness, and Doppler signals reveal increasing threat. Viability is time dependent. A threatened salvageable limb needs emergency reperfusion rather than avoidable diagnostic delay.
Coordinate reperfusion and systemic safety
Immediate vascular consultation, appropriate unfractionated heparin when not contraindicated, analgesia, and rapid endovascular or surgical planning are common elements. Embolic source, graft or stent thrombosis, bleeding, compartment syndrome, reperfusion injury, kidney risk, and systemic instability require parallel attention.
Define success as a functional recovery
Perfusion is necessary but not sufficient. Wound care, debridement when appropriate, infection management, pressure off-loading, nutrition, podiatry, rehabilitation, prosthetic planning when needed, cardiovascular prevention, housing, transport, and reliable follow-up determine whether the patient heals and remains mobile.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.